| Filed On | Filing |
|---|---|
| 16 Jun 2021 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying financial statements of Zikani Therapeutics, Inc. (the Company), which comprise the balance sheets as of December 31, 2020 and 2019, and the related statements of operations, changes in convertible prefer... |
| 13 Mar 2020 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 21 Jun 2019 |
8-K/A: Entry into a Material Definitive Agreement
Eloxx Pharmaceuticals, Inc. a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representative... |
| 16 Mar 2018 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 08 Mar 2018 |
8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year
The first paragraph under Item 5.03 of the Initial 8-K shall be amended and restated to say the following: |
| 25 Jul 2014 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheets of Fabrus, Inc. as of December 31, 2013 and 2012, and the related statements of operations, stockholders’ deficit, and cash flows for the years then ended and for the period from July 13, 2... |
| 08 Apr 2010 |
8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule
NEW BRUNSWICK, N.J. (April 8, 2010) – Senesco Technologies, Inc. (the “Company”) (NYSE Amex: SNT) has received a notice from the NYSE Amex LLC (“NYSE”) providing notification that, the Company does not meet one of the NYSE’s continued li... |
| 28 Nov 2007 |
8-K/A: Changes in Registrant's Certifying Accountant
We have read Senesco Technologies, Inc.’s statements included under item 4.01 of its Form 8-K/A, Amendment No. 2, filed on November 28, 2007, and we agree with such statements concerning our firm. |
| 20 Nov 2007 |
8-K/A: Changes in Registrant's Certifying Accountant
We have read Senesco Technologies, Inc.’s statements included under Item 4.01 of its Form 8-K/A filed on November 20, 2007, and we agree with such statements concerning our firm. |
| 01 Nov 2007 |
8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule
NEW BRUNSWICK, N.J. (November 1, 2007) —Senesco Technologies, Inc. (the “Company”) (AMEX: SNT), today issued a correction to its October 30, 2007 press release entitled “Senesco Technologies Update Notice from AMEX on Non-Compliance”. Th... |
| 15 Nov 2006 |
8-K/A: Entry into a Material Definitive Agreement
On November 8, 2006, Senesco Technologies, Inc. (the “Company”) entered into a License Agreement (the “Agreement”) with Bayer CropScience GmbH (“Bayer”) under which Bayer will exclusively license the rights to the Company’s proprietary g... |
Loading...